94094-54-9 Suppliers

Recommended suppliersmore

94094-54-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 94094-54-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,4,0,9 and 4 respectively; the second part has 2 digits, 5 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 94094-54:
(7*9)+(6*4)+(5*0)+(4*9)+(3*4)+(2*5)+(1*4)=149
149 % 10 = 9
So 94094-54-9 is a valid CAS Registry Number.

InChI:InChI=1/C18H15NO5/c1-11(20)19-14-7-9-17(22)15(10-14)16(21)8-4-12-2-5-13(6-3-12)18(23)24/h2-10,22H,1H3,(H,19,20)(H,23,24)/b8-4+

94094-54-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name	4-[3-(5-acetamido-2-hydroxyphenyl)-3-oxoprop-1-enyl]benzoic acid

1.2 Other means of identification

Product number	-
Other names	4-[3-(5-ACETAMIDO-2-HYDROXYPHENYL)-3-OXO-PROPEN-1-YL]BENZOIC ACID

1.3 Recommended use of the chemical and restrictions on use

Identified uses	For industry use only.
Uses advised against	no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number	-
Service hours	Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:94094-54-9 SDS

94094-54-9Upstream product

94094-54-9Downstream Products

94094-54-9Relevant articles and documents

COMPOUNDS FOR THE TREATMENT OF AMYLOID-ASSOCIATED DISEASES

-

Page/Page column 175, (2016/06/14)

This invention provides novel compounds of formulae (I) or (II) or a stereoisomer, enantiomer, racemic, or tautomer thereof, (I) (II) wherein the substituents are as defined in the specification. The present invention also relates to the novel compounds for use as a medicine, more in particular for the prevention or treatment of amyloid-related diseases, more specifically certain neurological disorders, such as disorders collectively known as tauopathies, disorders characterized by cytotoxic α-synuclein amyloidogenesis. The present invention also relates to the use of said novel compounds for the manufacture of medicaments useful for treating such amyloid-related diseases. The present invention further relates to pharmaceutical compositions including said novel compounds and to methods for the preparation of said novel compounds.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 94094-54-9

CAS

94094-54-9